RBC Capital Maintains GoHealth(GOCO.US) With Hold Rating, Maintains Target Price $13
Analysts Conflicted on These Financial Names: Bank Of Hawaii (BOH), Old National Bancorp Capital (ONB) and GoHealth (GOCO)
Noble Financial Maintains GoHealth(GOCO.US) With Buy Rating, Maintains Target Price $22
Noble Financial Sticks to Its Buy Rating for GoHealth (GOCO)
GoHealth Analyst Ratings
RBC Capital Maintains GoHealth(GOCO.US) With Hold Rating, Maintains Target Price $13
GoHealth (GOCO) Gets a Buy From Noble Financial
RBC Capital Remains a Hold on GoHealth (GOCO)
GoHealth (GOCO) Gets a Buy From Noble Financial
GoHealth Analyst Ratings
RBC Capital Remains a Hold on GoHealth (GOCO)
GoHealth (GOCO) Gets a Hold From RBC Capital
Analysts Conflicted on These Healthcare Names: GoHealth (GOCO) and Xenon (XENE)
Analysts Offer Insights on Healthcare Companies: GoHealth (GOCO), Viridian Therapeutics (VRDN) and Xenon (XENE)
RBC Raises Price Target on GoHealth to $15 From $14, Maintains Sector Perform Rating
Bank of America Securities Sticks to Its Sell Rating for GoHealth (GOCO)
Bank of America Securities Sticks to Their Sell Rating for GoHealth (GOCO)
Credit Suisse Raises GoHealth's Price Target to $8.50 From $7 After Model Update; Keeps Underperform Rating
Analysts Offer Insights on Financial Companies: Allstate (ALL), GoHealth (GOCO) and SoFi Technologies (SOFI)
Credit Suisse Maintains Underperform on GoHealth, Raises Price Target to $8.5
No Data
No Data